Diselenide-Bridged Doxorubicin Dimeric Prodrug: Synthesis and Redox-Triggered Drug Release.

Molecules · 2024 · PMC11052396 · PMID 38675530

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

Such understanding is quite significant to the design of smarter prodrugs for tumor-specific on-demand drug release in future tumor chemotherapy. 2.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.